Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
100 participants
INTERVENTIONAL
2024-04-26
2027-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Complete wound healing at 12 weeks (100% epithelialised)
% Reduction in wound area at 12 weeks
Participants will attend their NHS podiatry clinic appointment as normal and will be assigned either the study device or the current typical NHS standard of care device. Researchers will compare the study device group to the standard group to assess the outcomes mentioned previously.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sterile Wound Care Liquid Dressing in Treatment of Diabetic Ulcer in Necrosis Stable Stage: a Randomized Control Trial
NCT05975827
Evaluation of Negative Pressure Wound Therapy in the Treatment of DFUs Incl. Post Amputation Wounds.
NCT01011387
Treatment of Diabetic Foot Ulcers With AUP1602-C
NCT04281992
Efficacy and Safety Study in the Treatment of Chronic Diabetic Foot Ulcers
NCT00387101
Randomized Evaluation of Nonhealing Diabetic Foot Ulcers With Exclusive Wound Therapy
NCT07086443
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This clinical evaluation study will be performed under an open-label, comparative, design in the single health board of NHS Lanarkshire within 3 diabetic foot clinics.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Study Device
This Arm of the study will receive the study device. Although the Study Device is not experimental as it is already CE marked and being used for it's intended purpose.
Wound Dressing
RTD Wound Dressing that is being investigated
Standard of Care
This arm of the study will use the NHS' existing standard of care device as is normally used in podiatry clinics.
NHS Standard Dressing
This is the standard dressing used by NHS staff when currently dealing with a diabetic foot ulcer
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Wound Dressing
RTD Wound Dressing that is being investigated
NHS Standard Dressing
This is the standard dressing used by NHS staff when currently dealing with a diabetic foot ulcer
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* New presentation for treatment of a neuropathic, ischaemic or neuro- ischaemic non- infected DFU
* Subjects must be able to follow verbal and written instructions in English
* Subjects must have full mental capacity and able to give written informed consent to participation in the trial including medical photography for the purposes of the clinical trial or clinical care.
* DFU is \>10mm2 and \<100mm2
Exclusion Criteria
* Participants who will have problems following the protocol, including the offloading system, provided as standard of care, to wear on a daily basis
* Suspected malignancy in the wound
* Critical limb ischaemia
* Pregnant or breastfeeding females
* Women of childbearing potential and not using a medically accepted form of contraception when sexually active.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Keneric Healthcare
UNKNOWN
Community Pharmacology Services Ltd
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kaye McIntyre, MsC
Role: PRINCIPAL_INVESTIGATOR
NHS Lanarkshire
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
NHS Lanarkshire
Airdrie, North Lanarkshire, United Kingdom
NHS Lothian
Livingston, West Lothian, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Kaye McIntyre
Role: primary
Chris Jones
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CPS22.007
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.